ASCO 2025 may be over, but the insights are just beginning. This “Spotlight On” page is your hub for ongoing post-event coverage, including expert interviews, key takeaways, and video content ...

Bill Lundberg, Merus' president and CEO. For the second year running, data at ASCO on Merus' bispecific antibody petosemtamab in head and neck cancer has drawn the eye, as the company talks up its ...

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO ...

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to a prostate, testicular, and penile cancers poster session. Dr. Valentina Marulanda ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Sebastien Hotte discussing a biomarker-selected phase II study of durvalumab and tremelimumab ...

Highlights from ASCO Annual Meeting 2025 Hematology/Oncology June 12, 2025 41 min listen Preserving the Academic Mission with Sonali Smith, MD (Recorded LIVE at ASCO 2025) View more Podcasts ...